Dr. Mario Sznol
Claim this profileYale University
Area of expertise
Melanoma
Mario Sznol has run 6 trials for Melanoma. Some of their research focus areas include:
Lung Cancer
Mario Sznol has run 3 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Yale University
Yale School Of Medicine
Clinical Trials Mario Sznol is currently running
Voyager V1 + Cemiplimab
for Melanoma
This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will enroll patients with three distinct separate tumor cohorts. The cancers types are colorectal, head and neck carcinoma, and melanoma that are progressing on CPI treatment.
Recruiting
1 award
Phase 2
DF6002 + Nivolumab
for Advanced Cancer
This trial is testing a new drug, DF6002, alone and with an existing drug, Nivolumab, in patients with advanced solid tumors. These patients have cancers that are hard to treat with standard methods. DF6002 might help shrink or slow down tumors, while Nivolumab boosts the immune system to fight cancer.
Recruiting
1 award
Phase 1
5 criteria
More about Mario Sznol
Clinical Trial Related
5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Mario Sznol has experience with
- Pembrolizumab
- Nivolumab
- Cemiplimab
- DF6002
- VV1
- E-602
Breakdown of trials Mario Sznol has run
Melanoma
Lung Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mario Sznol specialize in?
Mario Sznol focuses on Melanoma and Lung Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Mario Sznol currently recruiting for clinical trials?
Yes, Mario Sznol is currently recruiting for 2 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Mario Sznol has studied deeply?
Yes, Mario Sznol has studied treatments such as Pembrolizumab, Nivolumab, Cemiplimab.
What is the best way to schedule an appointment with Mario Sznol?
Apply for one of the trials that Mario Sznol is conducting.
What is the office address of Mario Sznol?
The office of Mario Sznol is located at: Yale University, New Haven, Connecticut 06520 United States. This is the address for their practice at the Yale University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.